Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Menopause (New York, N.Y.)|January 27, 2026
Eight-session manualized cognitive behavioral therapy for anxiety and depression symptoms in perimenopause and postmenopause: a pilot studyLiisa Hantsoo, Dara G Friedman-Wheeler, Gabriela Lofland, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 16, 2026
Test-retest reliability of early TMS-evoked potentials over fMRI-based definitions of non-motor targetsCeyda Sayalı, Juha Gogulski, Ida Granö, et al.Biorxiv : the Preprint Server for Biology|May 22, 2023
A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.Molecules (Basel, Switzerland)|August 26, 2023
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight RadiotherapeuticsSrikanth Boinapally, Suresh Alati, Zirui Jiang, et al.International Journal of Nanomedicine|June 4, 2024
Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical EvaluationWojciech G Lesniak, Srikanth Boinapally, Gabriela Lofland, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 TherapeuticsAkhilesh Mishra, Dhiraj Kumar, Kuldeep Gupta, et al.Journal for Immunotherapy of Cancer|October 4, 2023
Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapyAkhilesh Mishra, Kuldeep Gupta, Dhiraj Kumar, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2022
Hetero-bivalent agents targeting FAP and PSMASrikanth Boinapally, Alla Lisok, Gabriela Lofland, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.Theranostics|April 14, 2025
EphA2-targeted alpha-particle theranostics for enhancing PDAC treatmentAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.Pageof 1